Hepatitis B virus (HBV) infection was highly endemic in China, where the prevalence of HBsAg was 9.7% in 1992. Comprehensive strategies, including universal infant hepatitis B vaccination with emphasis on timely birth-dose and 3-dose coverage, dramatically reduced the mother-to-infant transmission and early childhood acquisition of HBV, resulting in estimated HBsAg prevalence rates of 5.6% and 0.1% in the general population and among children aged <5 years in 2022, respectively. Clinical guidelines on the prevention and treatment of chronic hepatitis B have been periodically updated based on emerging evidence from clinical research. The continuously improved reimbursement policy and the massively reduced price of antiviral drugs through government negotiation and central procurement have increased treatment accessibility and affordability. However, due to the low rates of diagnosis and treatment, China still faces a large challenge in achieving the 2030 goal of lowering HBV-related mortality by 65%. A public health approach involving concerted efforts from the government, medical community, industry, and society as a whole would be necessary to increase the uptake of HBV tests and treatment to achieve the global goal of eliminating viral hepatitis as a public health threat by 2030.
Citations
Citations to this article as recorded by
Global, regional, and national burden and trends of liver cancer due to hepatitis B in young adults from 1990 to 2021 and forecast to 2030: insights from the Global Burden of Disease Study 2021 Jinbo Li, Yaling Li, Bihong Ke, Xiaosheng Zhang, Weigang Wang, Yandi Li, Jia Lian, Tian Yao, Keke Wang, Suping Wang, Yongliang Feng Internal and Emergency Medicine.2026; 21(1): 69. CrossRef
The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B Jiaxin Han, Lianxin Xu, Yuqin Li, Ziling Wang, Minghui Zeng, Jieru Gao, Yuqiang Mi, Wentao Kuai, Huiling Xiang, Liang Xu Frontiers in Immunology.2026;[Epub] CrossRef
Transjugular liver biopsy in patients with unexplained liver dysfunction and bleeding tendency: a safety and efficacy analysis Zhiyuan Zheng, Minjie Yang, Lili Ma, Jingqin Ma, Zihan Zhang, Jian Wang, Yuan Ji, Shiyao Chen, Jianjun Luo, Zhiping Yan, Xiaolin Wang, Wen Zhang BMC Gastroenterology.2026;[Epub] CrossRef
Breaking the stigma: the role of family support in hepatitis B management from a public health education perspective Lin Zhang, Junyi Chen, Guoxing Wu, Suhua Pang, Zhenjiang Zhang, Youde Yan Frontiers in Public Health.2026;[Epub] CrossRef
The Global Burden of Hepatitis B From 1990 to 2021: Trends, Socioeconomic Inequalities, and Predictions to 2035 Miaoqing Ye, Xinzhu Guan, Panyue Yan, Yujie Guan, Minying Li, Yilin Yang, Jinyu He, Wenping Liu, Dong Deng, Zhiwen Luo International Journal of Clinical Practice.2026;[Epub] CrossRef
Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students Xianwei Luo, Wenxiang Zhou, Shujie Zhou, Feiyang Song, Shouyan Geng, Haiyang Xu, Yuhui Cheng, Mingxue Ren, Yan Dong, Ling Lin, Leijing Mao, Binbing Wang, Yu Chai, Pengcheng Miao, Shaodi Ma, Jihai Tang Vaccines.2026; 14(4): 345. CrossRef
Spatiotemporal heterogeneity and socioeconomic determinants of syphilis incidence in Xining, Northwest China: a geospatial analysis Yitao Ren, Yongkai Shi, Ying Zhao, Lulu Fu, Jinxiong Lin, Wei Li BMC Infectious Diseases.2026;[Epub] CrossRef
Seroepidemiology of hepatitis B virus infection in apparently healthy adults in China: a nationwide study based on 17 million check-up adults Sailimai Man, Zhuoyan Yu, Jing Du, Jun Lv, Gang Li, Liming Li, Bo Wang Clinical and Molecular Hepatology.2026; 32(2): e199. CrossRef
Functional cure for chronic hepatitis B on hepatocellular carcinoma prevention: Evidence and clinical implications Wen Kang, Yu-Shen Liu, Tian-Ping Wang, Shu-Ming Zhang, Yu Li, Ye Zhang iLIVER.2026; 5(2): 100235. CrossRef
Characteristics and Screening Strategies of Hepatitis B in Guangdong Province, China Weizhao Lin, Xiaoping Shao, Junjie Wang, Hongqing Wen, Jiahong Liu, Can Xiong, Zixia Qian, Wei Zhao, Jun Liu, Jiufeng Sun Viruses.2026; 18(5): 486. CrossRef
Plasma gamma-glutamylglycine predicts the seroconversion of hepatitis B e antigen in patients with chronic hepatitis B Ze-Hua Zhao, Zheng-Jie Qu, Xin-Hua Guo, Xue-Qi Yang, Qi An, Fang-Ming Zhou, Jing-Hui Tian, Yu-Chen Fan Frontiers in Immunology.2026;[Epub] CrossRef
Maternal and infant growth outcomes following preconception antiviral therapy in chronic hepatitis B virus infection: A retrospective cohort study Xing-Ran Tao, Shi-Jing Gao, Jia Jia, Guorong Han Medicine.2026; 105(24): e49131. CrossRef
Spatiotemporal heterogeneity and influencing factors of hepatitis B in China: a 17-year national surveillance analysis Suxian Wang, Qingfeng Tian, Yaojun Zhao BMC Public Health.2026;[Epub] CrossRef
Medication adherence and associated factors in patients with chronic hepatitis B in Zhejiang Province, Eastern China Lu Shi, Canjie Zheng, Xinyue Chai, Xiaohong Wu, Hua Lin, Rui Yan, Xiaohua Qi, Yang Zhou BMC Public Health.2026;[Epub] CrossRef
The changing etiology of liver cancer: A comparative study of global and Chinese burden trends from hepatitis dominance to metabolic risks (1990-2021) and forecasts to 2035 Xue Zhou, Mingle Huang, Xiaofen Li, Minjie Zhao, Moushen Tang Liver Research.2026;[Epub] CrossRef
BEAT‐B Study (Behavior, Aspirations, and Treatment Needs): A Mixed‐Methods Study of Patient Values, Preferences, and Barriers to Care Among People Living With Chronic Hepatitis B in South and Southeast Asia Manya Prasad, Tushar Prabhakar, Priyanka Shenoy, Priyanka Aggarwal, Tawesak Tanwandee, K. C. Sudhamshu, M. Golam Azam, Zaigham Abbas, G. Vaishnavi, Vivekanandan Shanmugam, Bharat Bhushan Rewari, Shiv Kumar Sarin Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Optimizing pegylated interferon α‐2b consolidation duration and developing a recurrence prediction model after functional cure based on updated definition in chronic hepatitis B Yuchen Peng, Liping Liu, Xiaoping Wu European Journal of Medical Research.2026;[Epub] CrossRef
Comparable Predictive Performance of Non‐VCTE–Based Machine Learning Model for HBV‐Infected Hepatocellular Carcinoma Risk Hahn Yi, Hye Won Lee, Jae Il Shin, Hyung Woong Lee, Tae Seop Lim, Beom Kyung Kim, Namkug Kim Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Global inequality in the burden of hepatitis B from 1990 to 2021: Findings from the global burden of disease study 2021: Letter to the editor on “Comprehensive approach to controlling chronic hepatitis B in China” Chunlong Liu, Jiangtao Yu Clinical and Molecular Hepatology.2025; 31(2): e134. CrossRef
Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani Health Science Reports.2025;[Epub] CrossRef
Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure Yanxue Lin, Xueping Yu, Huimin Lin, Jiajia Han, Yan Yan, Xiaoting Zhao, Yijie Lin, Zixuan Huang, Yinyin Zheng, Yahong Gao, Wenjin Yuan, Meifang Zhou, Jiming Zhang, Dawu Zeng Alimentary Pharmacology & Therapeutics.2025; 62(5): 504. CrossRef
Construction and validation of a nomogram prediction model for antiviral efficacy based on clinical characteristics and intestinal microflora distribution in patients with chronic hepatitis B Hongjie Wu, Mingqiang Yue, Tianbao Wang, Xiaoxia Wei, Yanping Wang, Changyun Si Frontiers in Medicine.2025;[Epub] CrossRef
48-week prognostic analysis of very low-level viremia in patients with hepatitis B cirrhosis: a single-center retrospective study Yinong Feng, Zehong Wang, Shaoyuan Shi, Li Zhou, Yongli Hua, Xuanxuan Wang, Jianzhong Ma Frontiers in Medicine.2025;[Epub] CrossRef
Chinese medicine monomers for hepatocellular carcinoma: New ideas related to autophagy Shi-Hao Zheng, Tian-Yu Xue, Qiu-Yue Wang, Yong-An Ye, Peng Zhang World Journal of Gastroenterology.2025;[Epub] CrossRef
Trends in the disease burden of early-onset cancers in China from 1990 to 2021: a systematic analysis of the 2021 Global Burden of Disease study Jicun Zhu, Tiandong Li, Jiajun Chen, Wenhua Xue, Shuhong Liang, Chen Xie, Xiting Han, Weiwei Hao, Yixin He, Gaoxing Qiao, Xiaoran Duan, Lifeng Li, Jie Zhao BMC Cancer.2025;[Epub] CrossRef
Global Disease and Economic Burden of Noncommunicable Diseases Attributable to Hepatitis B Infection: A Health Economic Evaluation Study Xu Wang, Ningjun Ren, Hanting Liu, Jinzhao Xie, Yusheng Jie, Chun Hao, Stuart Gilmour, Jinghua Li, Jing Gu, Lei Zhang Journal of Medical Virology.2025;[Epub] CrossRef
Characterization of inflammatory protein expression patterns and their association with viral DNA load in hepatitis B virus infection via Olink proteomics analysis Xiangjuan Li American Journal of Translational Research.2025; 17(6): 4701. CrossRef
Epidemiological trends and projections to 2035 of hepatitis B burden in China, 1990–2021 Xinyue Qi, Yongzheng Hu, Wei Jiang, Pengpeng Ye, PLOS One.2025; 20(9): e0330633. CrossRef
Burden of liver cancer in adolescents and young adults aged 15-49 years in China: a comprehensive analysis based on the Global Burden of Disease study (1990-2021) Yi-Xin Zou, Zhuo-Ying Li, Xiao-Hui Zhou, Dan-Ni Yang, Jia-Yi Tuo, Qiu-Ming Shen, Yu-Ting Tan, Hong-Lan Li, Yong-Bing Xiang Hepatoma Research.2025;[Epub] CrossRef
Pretreatment viral quasispecies characteristics and evolutionary phases correlate with HBsAg seroconversion in peginterferon-alfa-2a-treated children with HBeAg-positive chronic hepatitis B Juncheng Yang, Guifeng Yang, Haitang He, Hai Liu, Qunfang Fu, Xiaoting Wu, Ran Meng, Zhuoyue Li, Qian Zhao, Kangxian Luo, Zhihua Liu Antiviral Research.2025; 244: 106291. CrossRef
Parental perceptions and willingness to pay for childhood vaccination experiences in China: a multi-city comprehensive evaluation study Bei Liu, Ninghua Huang, Yaqiong Liu, Xiyu Zhang, Bing Wu, Bing Cao, Tao Sun, Yudong Miao, Fuqiang Cui Vaccine.2025; 67: 127826. CrossRef
Global burden, trends and inequalities of hepatitis B among women of childbearing age, 1990–2021 Hong Zhang, Haitao Wang Annals of Medicine.2025;[Epub] CrossRef
Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study Wenyuan Zhang, Jia Chen, Wenjin Sun, Nana Xie, Fangbing Tian, Wencong Zhang, Qiurong Ruan, Jianxin Song Virology Journal.2025;[Epub] CrossRef
Effectiveness of the National Immunisation Programme and the catch-up vaccination on the incidence of hepatitis B in China: an interrupted time series analysis from 2005 to 2019 Bo-Wen Ming, Jinlun Zhang, Li Li, Xiaohan Xu, Chen Shi, Juanjuan Zhang, Chun-Quan Ou BMJ Global Health.2025; 10(11): e019080. CrossRef
Efficacy Analysis and Influencing Factors of HBsAg Response in Chronic Hepatitis B Patients Treated with Nucleoside Analogues and Pegylated Interferon Sequential Therapy with High HBsAg Levels Jingdan Chen, Shangkun Lai, Mijia Zheng Hepatitis Monthly.2025;[Epub] CrossRef
Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies Jiayi Zhang, Shuyan Chen, Jialing Zhou, Bingqiong Wang, Xiaoning Wu, Xiaoqian Xu, Xinyu Zhao, Yuanyuan Kong, Xiaojuan Ou, Yameng Sun, Hong You Gut and Liver.2025; 19(6): 889. CrossRef
Molecular mechanism of RBM15-mediated m6A modification in hepatitis B virus replication Min Ni, Bingbing Li, Lingli Wang, Shengju Ma, Kun Ma Virology Journal.2025;[Epub] CrossRef
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission Kailu Fang, Shuwen Li, Yushi Lin, Yu Zhang, Jie Wu BMC Public Health.2024;[Epub] CrossRef
Associations between chronic hepatitis B infection and inflammatory bowel diseases in East Asian populations Haiyan Ye, Deqin Wei, Yike Huang Future Virology.2024; 19(16-18): 563. CrossRef
First
Prev
